Clinical Trial Update: Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting results for rheumatoid arthritis patients who completed the preceding M13-390 study and were treated with adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-10-29